A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4045 (2006.01) A61P 21/00 (2006.01) A61P 25/02 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2615856
The present invention is directed to methods for the treatment of human patients afflicted with fibromyalglia using a non-ergot dopamine receptor D2/D3 agonist. In particular, patients are treated with a therapeutically effective amount of tetrahydro-benzthiazole or 3(H)-indolone compounds that are dopamine agonists. More specifically, the compounds 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzo--thiazole or 4-[2-(dipropylamino)-ethyl]-1,3-dihydro-2H-indol-2-one are administered to fibromyalgia patients to reduce the musculoskeletal pain symptoms associated with fibromyalgia.
La présente invention porte sur des méthodes destinées au traitement de patients humains atteints de fibromyalgie à l'aide d'un agoniste du récepteur D2/D3 de la dopamine non dérivé de l'ergot. Ce traitement vise particulièrement les patients traités avec une quantité thérapeutiquement efficace de composés dérivés de la tétrahydro-benzothiazole ou de la 3(H)-indolone qui sont des agonistes de la dopamine. Plus particulièrement, le 2-amino-6-n-propylamino-4,5,6,7-tétrahydrobenzo-thiazole ou le 4-¬2-(dipropylamino)-éthyl|-1,3-dihydro-2H-indol-2-one est administré à des patients atteints de fibromyalgie pour réduire la douleur musculosquelettique associée à la maladie.
Boehringer Ingelheim International Gmbh
Mbm Intellectual Property Law Llp
LandOfFree
Use of dopamine d2/d3 receptor agonists to treat fibromyalgia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of dopamine d2/d3 receptor agonists to treat fibromyalgia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dopamine d2/d3 receptor agonists to treat fibromyalgia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1507910